Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
Crossref DOI link: https://doi.org/10.1136/bmj.m1256
Published Online: 2020-03-26
Update policy: https://doi.org/10.1136/crossmarkpolicy
Tanne, Janice Hopkins
Text and Data Mining valid from 2020-03-26